134 related articles for article (PubMed ID: 9824491)
1. The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.
Wright RJ; Bikoff EK; Stockinger B
Immunology; 1998 Nov; 95(3):309-13. PubMed ID: 9824491
[TBL] [Abstract][Full Text] [Related]
2. Both invariant chain isoforms Ii31 and Ii41 promote class II antigen presentation.
Serwe M; Reuter G; Sponaas A; Koch S; Koch N
Int Immunol; 1997 Jul; 9(7):983-91. PubMed ID: 9237107
[TBL] [Abstract][Full Text] [Related]
3. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.
Zal T; Volkmann A; Stockinger B
J Exp Med; 1994 Dec; 180(6):2089-99. PubMed ID: 7964486
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
Honey K; Nakagawa T; Peters C; Rudensky A
J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
[TBL] [Abstract][Full Text] [Related]
6. The influence of invariant chain on the positive selection of single T cell receptor specificities.
Tourne S; Nakano N; Viville S; Benoist C; Mathis D
Eur J Immunol; 1995 Jul; 25(7):1851-6. PubMed ID: 7621862
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation and T cell development in H2-M-deficient mice.
Fung-Leung WP; Surh CD; Liljedahl M; Pang J; Leturcq D; Peterson PA; Webb SR; Karlsson L
Science; 1996 Mar; 271(5253):1278-81. PubMed ID: 8638109
[TBL] [Abstract][Full Text] [Related]
8. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.
Volkmann A; Barthlott T; Weiss S; Frank R; Stockinger B
J Exp Med; 1998 Sep; 188(6):1083-9. PubMed ID: 9743527
[TBL] [Abstract][Full Text] [Related]
9. B cells solicit their own help from T cells.
Stockinger B; Zal T; Zal A; Gray D
J Exp Med; 1996 Mar; 183(3):891-9. PubMed ID: 8642293
[TBL] [Abstract][Full Text] [Related]
10. Comparison of thymocyte development in normal and invariant chain-deficient mice provides evidence that maturation-related changes in TCR and co-receptor levels play a critical role in cell fate.
Huang LY; van Meerwijk JP; Bikoff EK; Germain RN
Int Immunol; 1996 Sep; 8(9):1429-40. PubMed ID: 8921421
[TBL] [Abstract][Full Text] [Related]
11. A new look at MHC and autoimmune disease.
Ridgway WM; Fassò M; Fathman CG
Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
[No Abstract] [Full Text] [Related]
12. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen.
Volkmann A; Zal T; Stockinger B
J Immunol; 1997 Jan; 158(2):693-706. PubMed ID: 8992985
[TBL] [Abstract][Full Text] [Related]
13. Normal thymic selection of TCR transgenic CD4 T cells, but impaired survival in the periphery despite the presence of selecting MHC molecules.
Barthlott T; Wright RJ; Stockinger B
J Immunol; 1998 Oct; 161(8):3992-9. PubMed ID: 9780168
[TBL] [Abstract][Full Text] [Related]
14. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
[TBL] [Abstract][Full Text] [Related]
15. Positive selection of self-MHC-reactive T cells by individual peptide-MHC class II complexes.
Barton GM; Beers C; deRoos P; Eastman SR; Gomez ME; Forbush KA; Rudensky AY
Proc Natl Acad Sci U S A; 2002 May; 99(10):6937-42. PubMed ID: 12011451
[TBL] [Abstract][Full Text] [Related]
16. Positive selection of CD4+ thymocytes controlled by MHC class II gene products.
MacDonald HR; Lees RK; Schneider R; Zinkernagel RM; Hengartner H
Nature; 1988 Dec; 336(6198):471-3. PubMed ID: 3264054
[TBL] [Abstract][Full Text] [Related]
17. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
18. Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells.
Adachi Y; Koseki H; Zijlstra M; Taniguchi M
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1200-4. PubMed ID: 7862661
[TBL] [Abstract][Full Text] [Related]
19. How the immune system learns about self.
von Boehmer H; Kisielow P
Sci Am; 1991 Oct; 265(4):74-81. PubMed ID: 1836069
[No Abstract] [Full Text] [Related]
20. The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.
Thompson JA; Srivastava MK; Bosch JJ; Clements VK; Ksander BR; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2008 Mar; 57(3):389-98. PubMed ID: 17724589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
